Viral Clearance Market Size, Share & Forecast | 2020-25

Viral Clearance Market Insights

Viral clearance market is likely to witness an impressive CAGR of 22.3% during the forecast period. Growth in the pharmaceutical and biotechnology industries, R&D investment in life science, surge in number of drug launches, developments in nanofiltration technology, and increasing burden of chronic diseases are the major factors that are contributing towards the growth of the viral clearance market. 

Wish to Get a Free Sample? Click here.

Viral Clearance Market Share: By End-User Type

Based on the end-user type, the market is segmented as pharmaceutical & biotechnology companies, contract research organizations, academic research institutes, and others. The contract research organizations’ segment is expected to portray the highest growth during the forecast period. Ability of contract research organizations to invest extensively in drug discovery infrastructure and increased outsourcing of drug discovery services to CROs by institutions, such as start-ups, academic institutes, pharmaceutical companies, and small biotechnology companies are the major factors behind their extraordinary growth in the global viral clearance market.

Viral Clearance Market Share: By Method Type

Based on the method type, the viral clearance market is segmented as viral removal and viral inactivation. The viral removal segment is expected to lead the market during the forecast period owing to growth in R&D activities by biopharmaceutical companies; high accuracy, speed, and flexibility provided by the method in life sciences research, and increasing acceptance of the method in the industry.

Viral Clearance Market Share: By Region

In terms of regions, North America dominated the viral clearance market and is expected to witness substantial growth during the forecast period. Presence of national institutes supporting life science and biotechnology research, significant growth in the pharmaceutical industry, and continuous increase in drug approvals are the major factors driving the viral clearance market in the region. Asia-Pacific is expected to witness the highest growth during the forecast period, owing to government support in countries, such as China, Japan, and India; rise in pharmaceutical R&D expenditures, government support and rising awareness towards generic drugs, along with the increasing number of CROs to provide preclinical and clinical research services.

Some of the major players in the viral clearance market are Merck Group, Charles River Laboratories, Inc., Kedrion S.p.A., Vironova AB, Texcell, Clean Cells, BSL BIOSERVICE Scientific Laboratories Munich GmbH, and ViruSure GmbH.

Market Scope & Segmentation

Viral Clearance is removing of viral contamination through chromatography or by making use of some specialized membranes. The process of viral clearance is done in order to make sure that drugs from different sources are free from any kind of viral contamination.

Viral Clearance can take through the method of viral removal and viral inactivation. The process is used for different options such as blood or blood products, recombinant proteins, vaccines, and others. Biotechnology and pharmaceutical companies, academic research institutes, and contract research organizations are some of the places where the process is highly needed.

This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

The viral clearance market is segmented into the following categories. 

Viral Clearance Market, by Application Type:

• Recombinant Proteins (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Blood and Blood Products (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Vaccines (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Others (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

Viral Clearance Market, by End-User Type:

• Pharmaceutical & Biotechnology Companies (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Contract Research Organizations (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Academic Research Institutes (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Others (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

Viral Clearance Market, by Method Type:

• Viral Removal 
  • (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
  • (Method Type Analysis: Chromatography, Nanofiltration, and Precipitation)
• Viral Inactivation
  • (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
  • (Method Type Analysis: Low Ph, Solvent Detergent Method, Pasteurization, and Others)

Viral Clearance Market, by Region:

• North America (Country Analysis: the USA, Canada, and Mexico) 
• Europe (Country Analysis: Germany, France, the UK, Russia, and Rest of Europe)
• Asia-Pacific (Country Analysis: China, Japan, India, and Rest of Asia-Pacific)
• Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

Research Methodology

This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

• Market structure: Overview, industry life cycle analysis, supply chain analysis
• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
• Market trend and forecast analysis
• Market segment trend and forecast
• Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
• Attractive market segments and associated growth opportunities
• Emerging trends
• Strategic growth opportunities for the existing and new players
• Key success factors

Report Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to 3 players)
• SWOT analysis of key players (up to 3 players)

Market Segmentation

• Current market segmentation of any one of the method types by application type.  

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].